Hydrochloric Acid

Hydrochloric Acid

SCHEMBL1123530

CCCCCCN=C(N)N.Cl

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
MAOA known ✓ P21397 1/20 0.54
MAOB known ✓ P27338 1/20 0.54
MEN1 O00255 2/20 0.95
KMT2A Q03164 2/20 0.95
DHPS P49366 1/20 0.58
PRSS1 P07477 1/20 0.58
PRSS2 P07478 1/20 0.58
PRSS3 P35030 1/20 0.58
CYP1A2 P05177 2/20 0.54
ALOX15 P16050 1/20 0.54
NFKB1 P19838 1/20 0.54
LMNA P02545 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8818186 1.00 MEN1 (0.95) MEN1KMT2ADHPSPRSS1PRSS2
Hydrochloric Acid SCHEMBL5319582 1.00 MEN1 (0.95) MEN1KMT2ADHPSPRSS1PRSS2
Hydrochloric Acid SCHEMBL4168696 1.00 MEN1 (0.95) MEN1KMT2ADHPSPRSS1PRSS2
Dodine SCHEMBL560209 1.00 MEN1 (0.95) MEN1KMT2ADHPSPRSS1PRSS2
Hydrochloric Acid SCHEMBL899169 1.00 MEN1 (0.95) MEN1KMT2ADHPSPRSS1PRSS2
Hydrochloric Acid SCHEMBL27504627 1.00 MEN1 (0.95) MEN1KMT2ADHPSPRSS1PRSS2
Hydrochloric Acid SCHEMBL4461585 1.00 MEN1 (0.95) MEN1KMT2ADHPSPRSS1PRSS2
SCHEMBL1138747 0.97 MEN1 (1.00) MEN1KMT2ADHPSPRSS1PRSS2
SCHEMBL5300899 0.97 MEN1 (1.00) MEN1KMT2ADHPSPRSS1PRSS2
SCHEMBL4104867 0.97 MEN1 (1.00) MEN1KMT2ADHPSPRSS1PRSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 357 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119688806-A Sensor function network system for marine environment integration and preparation method thereof 东方国际集团上海环境科技有限公司 2025-03-25 CN claimed
CN-119433756-A Antibacterial self-lubricating composite fiber and preparation method thereof 东方国际集团上海环境科技有限公司 2025-02-14 CN claimed
CN-117987952-A Preparation method of stock solution coloring polylactic acid fiber 中国石油化工股份有限公司 2024-05-07 CN claimed
CN-117737885-A High-air-permeability cloth and preparation process thereof 喀什浩朋服装科技有限公司 2024-03-22 CN claimed
CN-117627305-A Degradable stone-plastic floor and preparation method thereof 浙江海象新材料股份有限公司 2024-03-01 CN claimed
CN-117177641-A Method for preparing perovskite precursor solution and perovskite photovoltaic cell 极电光能有限公司 2023-12-05 CN claimed
CN-114854161-B Antibacterial deodorizing super absorbent resin and preparation method thereof 中国科学院长春应用化学研究所 2023-10-13 CN claimed
CN-116349679-A Composite disinfection and sterilization method 孙国明 2023-06-30 CN claimed
CN-111393637-B Modified polyguanidine salt antibacterial mildew inhibitor, preparation method thereof and application thereof in silicone structural sealant 安阳崇高纳米材料科技有限公司 2023-03-31 CN claimed
CN-115770254-A Preparation method of burn cleaning solution 山东舒达生物科技有限公司 2023-03-10 CN claimed
CN-106380598-A Synthesis method and application of high-polymer ionic liquid 石家庄学院 2017-02-08 CN claimed
EP-2910124-A1 STIMULANT AND METHOD FOR STIMULATING PLANT GROWTH AND DEVELOPMENT Obshchestvo S Ogranichennoy Otvetstvennostyu "Nanobiotekh" (RU) 2015-08-26 EP claimed
CN-103920180-A Chitosan hydrogel for antibacterial dressing and preparation method thereof SHANGHAI INST TECHNOLOGY 2014-07-16 CN claimed
WO-2007101445-A1 BIOCIDAL CLEANING COMPOSITIONS GLAD, THOMAS CHRISTIAN (DK) 2007-09-13 WO claimed
US-20070071702-A1 Use of a polyguanidine compound for treating or shaping the hair, especially for straightening or permanent-waving it PHILIPPE MICHEL 2007-03-29 US claimed
EP-1302194-B1 Use of a polyguanidine compound for treating or styling hair, especially for straightening or permanent waving OREAL (FR) 2006-07-05 EP claimed
US-20030133898-A1 Use of polyguanidine compound for treating or shaping the hair, especially for straightening or permanent-waving it L'OREAL (FR) 2003-07-17 US claimed
EP-0619272-B1 Method for the purification of waste water containing silver AGFA GEVAERT NV (BE) 1998-03-04 EP claimed
US-5423990-A Method for the purification of waste water containing silver AGFA-GEVAERT, N.V. (BE) 1995-06-13 US claimed
EP-0619272-A1 Method for the purification of waste water containing silver AGFA-GEVAERT N.V. (BE) 1994-10-12 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070071702-A1 Use of a polyguanidine compound for treating or shaping the hair, especially for straightening or permanent-waving it KRT18, PTMA, PARG MAOA 1027/4885MAOB 1653/4885MEN1 2462/4885
US-20030133898-A1 Use of polyguanidine compound for treating or shaping the hair, especially for straightening or permanent-waving it KRT18, PTMA, PARG MAOA 1000/4885MAOB 1602/4885MEN1 2672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.